Critical Gatekeepers in Cancer Therapy and Prognosis, the Claudin Protein Family
July 25, 2024

The Claudin protein family is essential in tight junctions, regulating ion and water flow between cells and maintaining tissue integrity to prevent cancer cell migration. Abnormal Claudin expression is linked to tumor growth and metastasis, making them key targets for cancer therapy and prognosis. This protein family’s complex three-dimensional structures are vital for antibody targeting. Dr. Spencer Chiang of ACROBiosystems highlights the need for producing full-length Claudin proteins to ensure correct antibody interactions. ACROBiosystems aids the pharmaceutical and biotechnology industries by offering innovative tools and solutions, such as recombinant proteins and assay kits, to support drug development from research to clinical phases.
To read more, click here.
[Source: News Medical, July 24th 2024.]